DERMASENSOR
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer evaluation, given that the majority of Americans report never having been checked for skin cancer. The DermaSensor device is an affordable, handheld tool that uses machine learning and spectroscopy to objectively evaluate skin lesions for potential cancer in seconds.
DERMASENSOR
Social Links:
Industry:
Biotechnology Health Care Medical Medical Device
Founded:
2009-05-01
Address:
Miami, Florida, United States
Country:
United States
Website Url:
http://www.dermasensor.com.au
Total Employee:
11+
Status:
Active
Contact:
4153220838
Email Addresses:
[email protected]
Total Funding:
34.55 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Font Awesome
Similar Organizations
ITeos Therapeutics
ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.
PanTheryx
PanTheryx is a nutrition and biotechnology company that utilizes the cellular and biomolecular processes of bovine colostrum.
Praxis Precision Medicines
Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Advisors List
Current Employees Featured
Founder
Investors List
Ernest Bachrach
Ernest Bachrach investment in Series B - DermaSensor
Ceros Capital Markets
Ceros Capital Markets investment in Series B - DermaSensor
Maurice Ferre, M.D.
Maurice Ferre, M.D. investment in Series B - DermaSensor
Alberto Beeck
Alberto Beeck investment in Series B - DermaSensor
MedTech Innovator
MedTech Innovator investment in Non Equity Assistance - DermaSensor
SternAegis
SternAegis investment in Series B - DermaSensor
Christopher Dewey
Christopher Dewey investment in Series A - DermaSensor
David Matlin
David Matlin investment in Series A - DermaSensor
Miami Angels
Miami Angels investment in Series A - DermaSensor
Maurice Ferre, M.D.
Maurice Ferre, M.D. investment in Series A - DermaSensor
Official Site Inspections
http://www.dermasensor.com.au Semrush global rank: 4.43 M Semrush visits lastest month: 2.5 K
Unable to get host informations!!!
More informations about "DermaSensor"
Derma Sensor - Overview, News & Similar companies - ZoomInfo
Jul 6, 2022 View Derma Sensor (www.dermasensor.com.au) location in Victoria, Australia , revenue, industry and description. Find related and similar companies as well as employees …See details»
DermaSensor - Crunchbase Company Profile & Funding
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer evaluation, given that the majority of …See details»
Advanced Skin Cancer & Melanoma Detection Technology
DermaSensor’s algorithm analyzes spectral data and delivers skin cancer risk results in seconds. Advanced AI and Optical Spectroscopy in the Palm of Your Hand. Proven Clinical Utility. The …See details»
Derma Sensor Company Profile | Management and Employees List …
[email protected]: Derma Sensor Top Competitors. Company Employees Revenue Top technologies; MetaOptima Technology. 34: $7.1 M: Eastern Skin Cancer Clinic. 5: $1.1 M: …See details»
History: Our Journey in Skin Cancer Detection
DermaSensor began its own skin-specific studies using this technology in 2011 and began its first study on the current commercial device in 2018. Building a Groundbreaking Device. DermaSensor was founded in 2009 to improve …See details»
DermaSensor - Company Profile
DermaSensor. Now cleared by the U.S. Food and Drug Administration (FDA), DermaSensor equips physicians with immediate, accurate, and objective results that improve skin cancer …See details»
DermaSensor 2025 Company Profile: Valuation, …
How much funding has DermaSensor raised over time? DermaSensor has raised $50.7M. Who are DermaSensor’s investors? Pier 70 Ventures, Wealthing VC Club, , Ceros Capital Markets, and are 5 of 16 investors who have invested in …See details»
How DermaSensor Works
DermaSensor Inc. is a Miami-based connected medical device company that seeks to enable healthcare professionals to efficiently check for skin cancer by leveraging cutting-edge …See details»
DermaSensor - Company Profile - Tracxn
Feb 13, 2025 DermaSensor. has raised a total funding of $44.7M over 5 rounds. Its first funding round was on Dec 18, 2018. List of recent funding rounds of DermaSensor. Date of funding. …See details»
DermaSensor ANZ - Org Chart, Teams, Culture & Jobs | The Org
View DermaSensor ANZ's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. Explore. Vision. Log in. Sign up. …See details»
DermaSensor Company Profile - Office Locations, Competitors
DermaSensor has 5 employees at their 1 location and $10 m in total funding,. See insights on DermaSensor including office locations, competitors, revenue, financials, executives, …See details»
DermaSensor Inc. Information - RocketReach
Now cleared by the U.S. Food and Drug Administration (FDA), DermaSensor equips physicians with immediate, accurate, and objective results that improve skin cancer detection through …See details»
DermaSensor, Inc. Company Overview, Contact Details
Jun 4, 2020 Dermasensor launched DERM-ASSESS III study data on Jul 13th '23. MIAMI, July 13, 2023, Business Wire - DermaSensor Inc., a health technology company equipping primary …See details»
Skin Cancer Evaluation. - DermaSensor
Of the DermaSensor device.1 1 5 2 6 3 7 4 8 In a randomized, prospective study of DermaSensor utility with 57 GPs, physicians made over 5,000 assessments of skin lesions. The study …See details»
Board of Directors | DermaSensor
A Board Observer for DermaSensor, Russell is a serial entrepreneur and executive (CEO, CMO) of digital health and medical device companies. Prior to his entrepreneurial career, Russell …See details»
DermaSensor - Products, Competitors, Financials, Employees ...
DermaSensor, an FDA-approved device for AI melanoma detection, was not studied in skin of color prior to approval, with data leading to its approval including only white patients. The FDA …See details»
Learnings from the first AI-enabled skin cancer device for ... - Nature
Jun 15, 2024 The U.S. Food and Drug Administration’s (FDA) recent authorization of DermaSensor, an AI-enabled device for skin cancer detection in primary care, marks a pivotal …See details»
The Future of Skin Cancer Detection - dermasensor.com
At Sanctum Med + Wellness, we deliver exceptional healthcare services prioritizing patient well-being and addressing every aspect of their health. Adding the DermaSensor device to our …See details»
Skin Cancer Diagnostics for Health Systems - DermaSensor
DermaSensor’s capabilities pave the way for more informed decision-making, since the device was found to have a 96% device sensitivity for correctly referring skin cancer in a study of …See details»
Safety and Effectiveness Results for DERM-ASSESS II
DermaSensor’s and dermatologists’ sensitivity and specifi city. DermaSensor’s sensitivity for melanoma was 95% while the study dermatologists’ was 90%. For non-melanoma skin cancer …See details»